SCRC Stock UPDATES Scripsamerica Inc (SCRC) 0.0901 08/03/2014

New Post Public Reply Private Reply Replies (0) Message Board

Aug 3, 2014 at 4:35 AM

Scripsamerica Inc (SCRC) 0.0901 $SCRC

ScripsAmerica's Managed Specialty Pharmacy on Pace for Record Month
Marketwire - Mon Jul 21, 7:01AM CDT
ScripsAmerica, Inc. (OTCBB: SCRC) today announced that the Company's managed specialty pharmacy reported $1.5 million in approved prescription orders during the first half of July.

Wholesale Rx, ScripsAmerica's Equity Venture, Reports Significant YoY Revenue Growth During Q2 2014
Marketwire - Mon Jul 14, 7:30AM CDT
ScripsAmerica Inc. (OTCBB: SCRC), a leading supplier of prescription, OTC and nutraceutical drugs, today announced that the Company's equity venture, Wholesale Rx "WRx," received and processed $696,808 in orders during the quarter ended June 30, 2014 compared to $26,000 during the same quarter in 2013, prior to ScripsAmerica's involvement with the company.

ScripsAmerica's Equity Venture, Wholesale Rx, Reports 93% Revenue Growth During the First Quarter of 2014
Marketwire - Wed Jul 09, 7:30AM CDT
ScripsAmerica Inc. (OTCBB: SCRC), a leading supplier of prescription, OTC and nutraceutical drugs, today announced that the Company's equity venture, Wholesale Rx "WRx," reported quarterly revenue growth of 93% from Q4 2013 to Q1 2014.

ScripsAmerica's Managed Specialty Pharmacy Receives Approved Orders of $2.7 Million in June
Marketwire - Mon Jul 07, 7:30AM CDT
ScripsAmerica, Inc. (OTCBB: SCRC) today announced that the Company's managed specialty pharmacy reported $2,706,709 in prescription approved orders during the month of June.

ScripsAmerica Completes Prepayment of Outstanding Convertible Debt
Marketwire - Mon Jun 23, 8:15AM CDT
ScripsAmerica, Inc. (OTCBB: SCRC) today announced that the Company has completed the prepayment of its outstanding convertible debt.

ScripsAmerica Announces CEO Interview With Stock Legends Radio
Marketwire - Tue Jun 10, 9:02AM CDT
ScripsAmerica Inc. (OTCBB: SCRC), a leading supplier of prescription, OTC and nutraceutical drugs, today announced that Stock Legends recently conducted an audio interview with the Company's Chief Executive Officer, Bob Schneiderman.

ScripsAmerica Enters Supply Agreement With RapiMed(R) Manufacturer
Marketwire - Mon Jun 09, 7:30AM CDT
ScripsAmerica Inc. (OTCBB: SCRC), a leading supplier of prescription, OTC and nutraceutical drugs, today announced that the Company has signed a 2-year manufacturing supply agreement with the manufacturer of its RapiMed(R) children's pain reliever and fever reducer.

ScripsAmerica's Specialty Pharmacy Records Monthly Revenue of $1.6 Million in May
Marketwire - Mon Jun 02, 8:41AM CDT
ScripsAmerica, Inc. (OTCBB: SCRC) today announced that its managed specialty pharmacy reported $1.6 million in prescription sales during the month of May.

New Business Model Equals Increasing Revenues for ScripsAmerica Analyst Report
PR Newswire - Thu May 29, 6:00AM CDT
ScripsAmerica, Inc. (OTCQB: SCRC) offers fulfillment of prescription and over the counter drug orders. To fulfill purchase orders from customers, the company processes orders to the end user's desired specifications. The company's capabilities range from unit of use packaging for in-patient nursing homes and hospitals to bulk packaging for government and international organizations.

ScripsAmerica Files Suit Against Ironridge Global IV, Ltd. in Federal Court
Marketwire - Tue May 27, 8:30AM CDT
ScripsAmerica Inc. (OTCBB: SCRC), today announced that on May 22, 2014, ScripsAmerica Inc. filed a lawsuit against Ironridge Global IV, Ltd. ("Ironridge"

, its principals and certain other defendants in the Federal district court for the Central District of California.

ScripsAmerica Reports 126% Quarterly Revenue Growth YoY During Q1 2014
Marketwire - Wed May 21, 7:00AM CDT
ScripsAmerica Inc. (OTCBB: SCRC) today announced the filing of its 10Q for the quarter that ended March 31, 2014.

ScripsAmerica Issues Second Payment on Largest Convertible Note
GlobeNewswire - Wed Apr 02, 8:43AM CDT
ScripsAmerica Inc. (OTCBB:SCRC), today announced that the Company has issued the second payment due on its convertible note with the largest principal and closest conversion date.

ScripsAmerica Reports March Revenue of Over $494,000 for Its Managed Specialty Pharmacy
GlobeNewswire - Tue Apr 01, 8:25AM CDT
ScripsAmerica, Inc. (OTCBB:SCRC) today announced that the specialty pharmacy it recently entered into a management agreement with recorded $494,643 in prescription sales for the month of March.

ScripsAmerica Prepays $50,000 Convertible Promissory Note
GlobeNewswire - Mon Mar 31, 7:30AM CDT
ScripsAmerica Inc. (OTCBB:SCRC), a leading supplier of prescription, OTC and nutraceutical drugs, today announced the prepayment of an outstanding convertible note in the principal amount of $50,000.

ScripsAmerica's Pharmaceutical Equity Venture, Wholesale Rx, Continues Revenue Growth in February
GlobeNewswire - Mon Mar 24, 7:33AM CDT
ScripsAmerica Inc. (OTCBB:SCRC), a leading supplier of prescription, OTC and nutraceutical drugs, today announced that the Company's equity venture, Wholesale Rx "WRx," received and processed $313,904 in orders during the month of February.

ScripsAmerica Prepays Another Convertible Promissory Note
GlobeNewswire - Mon Mar 17, 7:30AM CDT
ScripsAmerica Inc. (OTCBB:SCRC), a leading supplier of prescription, OTC and nutraceutical drugs, today announced that the Company has prepaid the entire balance of an outstanding convertible promissory note with a principal amount of $50,000.

ScripsAmerica Announces Prepayment of Convertible Promissory Note
GlobeNewswire - Wed Mar 12, 7:46AM CDT
ScripsAmerica Inc. (OTCBB:SCRC), a leading supplier of prescription, OTC and nutraceutical drugs, today announced that the Company has prepaid the balance of an outstanding convertible promissory note with a principal amount of $40,000.

ScripsAmerica Secures $200,000 RapiMed Purchase Order for Hong Kong Market
GlobeNewswire - Mon Mar 10, 9:02AM CDT
ScripsAmerica, Inc. (OTCBB:SCRC) today announced that the Company has secured a $200,000 purchase order for RapiMed(R) from Global Pharma Hub for the Hong Kong market.

ScripsAmerica Enters Licensing Agreement to Market and Distribute RapiMed in Canada
GlobeNewswire - Wed Mar 05, 7:30AM CST
ScripsAmerica, Inc. (OTCBB:SCRC) today announced that the Company has entered into a sublicensing agreement for the marketing and distribution of RapiMed(R) in Canada. ScripsAmerica will now have access to the growing Canadian OTC drug market, which was valued at over $3.1 Billion in 2012.

ScripsAmerica Signs Business Management Agreement With a New Jersey Compounding Pharmacy
GlobeNewswire - Thu Feb 20, 7:30AM CST
ScripsAmerica, Inc. (OTCBB:SCRC) today announced that the Company has entered into a business management agreement with a New Jersey compounding pharmacy.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Community in Shock After Fatal Bakersfield Shooting

The Ripple Effect of Tragedy Grief has a way of shaking a community down to its core—especially when the loss emanates from such senseless violence as the shooting death of 17-year-old Levi Brown. This wasn't just a tragic occurrence at a Friday night football game in Bakersfield; it was a visceral crack in the perceived safety of community events. Levi's Legacy and...

Vantrue's Black Friday Dash Cam Deals: Save up to 44%

Kicking Off Early Black Friday with Dash Cam Bargains In a bid to stay ahead of the holiday shopping rush, Vantrue announced its early Black Friday campaign with a range of discounts designed to capture the interest of road warriors and casual drivers alike. From November 1 to November 21, 2026, Vantrue is inviting bargain hunters to explore their offerings—culminating...

Firefox Champions Privacy with Iconic Internet Campaign

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Sinclair Faces Labor Lawsuit for Break-time Violations

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Ping An's Bold Green Moves Ahead of APEC 2026

By Owen Jenkins Updated Oct 25, 2026 Category News Views 201

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...